Kay Bross has been named Program Director, Member and Vendor Relations for SAFE-BioPharma Association, the non-profit association that created and manages the SAFE-BioPharma® digital identity and digital signature standard for the pharmaceutical and healthcare industries.
Ms. Bross, who served as a member of the association’s Board of Directors, is responsible for building and managing relationships with the association’s growing member and vendor-partner communities. She also is responsible for business development and alliance management. SAFE-BioPharma members include many of the world’s largest biopharmaceutical companies and, increasingly, smaller companies that want to benefit from the time and cost-saving efficiencies of the SAFE-BioPharma standard.
“We are fortunate that Kay Bross is available at this point in the association’s development. As a former member of our board and someone who understands both the standard and the community it serves, she will be a valuable asset to the association’s development,“ said Mollie Shields-Uehling, president and CEO, SAFE-BioPharma Association.
Kay Bross is an authority in the area of electronic document management (EDM). She recently retired from Procter & Gamble, where she managed operations associated with Regulatory submissions data and developed the company’s corporate intranet virtual library. As a member of P&G’s Global Business Solutions, Information Security unit, she introduced the SAFE-BioPharma standard.
Ms. Bross also is recognized in the international EDM community. She co-chaired several annual Drug Information Association (DIA) Electronic Document Management Conferences and served on numerous DIA program committees. She is a frequent EDM speaker and panelist. She has served as a member of the SAFE-BioPharma Board of Directors.
Ms. Bross holds an MEd from Xavier University, Cincinnati and a BA from Emporia State University, Emporia, Ks.
About SAFE-BioPharma Association (www.safe-biopharma.org) SAFE-BioPharma Association is the non-profit association that created and manages the SAFE-BioPharma® digital identity and signature standard for the pharmaceutical and healthcare industries. It provides users with a secure, enforceable, and regulatory compliant way to verify identities of parties involved in electronic transactions and to apply digital signatures to electronic documents.
The Association’s members include:
- Abbott (NYSE: ABT)
- Amarin Corp. (NASDAQ: AMRN)
- Amgen (NASDAQ: AMGN)
- AstraZeneca (NYSE: AZN)
- Bristol-Myers Squibb (NYSE: BMY)
- GlaxoSmithKline (NYSE: GSK)
- Johnson & Johnson (NYSE: JNJ)
- Eli Lilly (NYSE: LLY)
- McDougall Scientific
- Merck (NYSE: MRK)
- MWB Consulting Limited
- National Notary Association
- Novartis (NYSE: NVS)
- Oxford Outcomes
- Pfizer (NYSE: PFE)
- Premier Inc.
- Sanofi-Aventis (NYSE: SNY)
- ScheringPlough-Organon (NYSE: SGP)
- SNAP Diagnostics
SAFE-BioPharma® is a trademark of SAFE-BioPharma Association. Any use of this trademark requires approval from SAFE-BioPharma Association.